US Stock MarketDetailed Quotes
IDGGW INTERPACE BIOSCIENCES INC C/WTS 21/06/2022 (TO PUR COM)
- 0.000000
- 0.0000000.00%
15min DelayClose Dec 26 09:30 ET
0Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)4.17MShares0.00040052wk High0.00P/B0Float Cap0.00030052wk Low--Dividend TTM4.17MShs Float0.295000Historical High--Div YieldTTM0.00%Amplitude0.000300Historical Low--Avg Price1Lot Size
INTERPACE BIOSCIENCES INC C/WTS 21/06/2022 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.53%10.38M | 27.52%41.31M | 12.51%10.85M | 14.84%9.47M | 104.83%11.16M | 8.54%9.83M | 33.77%32.4M | 128.85%9.65M | 6.77%8.25M | -13.14%5.45M |
| Operating revenue | 5.53%10.38M | 27.52%41.31M | 12.51%10.85M | 14.84%9.47M | 104.83%11.16M | 8.54%9.83M | 33.77%32.4M | 128.85%9.65M | 6.77%8.25M | -13.14%5.45M |
| Cost of revenue | 1.28%5.38M | 7.83%23.37M | -1.73%6.4M | 12.59%5.85M | 50.65%5.8M | -13.04%5.32M | 36.41%21.67M | 20.71%6.52M | 7.43%5.19M | 27.02%3.85M |
| Gross profit | 10.54%4.99M | 67.32%17.95M | 42.19%4.45M | 18.66%3.62M | 235.53%5.36M | 53.33%4.52M | 28.72%10.73M | 364.27%3.13M | 5.67%3.05M | -50.73%1.6M |
| Operating expense | -1.95%6.94M | -14.47%29.68M | -21.18%7.7M | -13.26%7.26M | 5.44%7.64M | -23.40%7.08M | 7.51%34.7M | 1.47%9.77M | -8.85%8.37M | -0.64%7.24M |
| Selling and administrative expenses | 14.56%6.11M | -13.52%23.74M | -17.75%6.57M | -11.70%5.73M | 9.37%6.1M | -27.17%5.33M | 7.72%27.45M | 3.20%7.99M | -10.42%6.49M | -2.92%5.58M |
| -Selling and marketing expense | 2.76%2.42M | 8.79%10.07M | 0.16%2.48M | -9.00%2.46M | 73.93%2.78M | -5.24%2.35M | -16.75%9.25M | -17.10%2.48M | -2.10%2.7M | -46.06%1.6M |
| -General and administrative expense | 23.87%3.69M | -24.86%13.67M | -25.81%4.09M | -13.62%3.28M | -16.50%3.33M | -38.41%2.98M | 26.66%18.19M | 15.98%5.51M | -15.52%3.8M | 42.86%3.98M |
| Research and development costs | -53.06%299K | -32.67%1.88M | -39.43%407K | -45.48%416K | -22.91%424K | -21.26%637K | -0.53%2.8M | -13.62%672K | -10.97%763K | -14.99%550K |
| Depreciation amortization depletion | -51.80%536K | -8.90%4.06M | -34.71%728K | -0.27%1.11M | -0.27%1.11M | -0.27%1.11M | 11.83%4.46M | 0.00%1.12M | 3.34%1.12M | 24.30%1.12M |
| -Depreciation and amortization | -51.80%536K | -8.90%4.06M | -34.71%728K | -0.27%1.11M | -0.27%1.11M | -0.27%1.11M | 11.83%4.46M | 0.00%1.12M | 3.34%1.12M | 24.30%1.12M |
| Operating profit | 23.97%-1.95M | 51.05%-11.74M | 51.02%-3.26M | 31.59%-3.64M | 59.58%-2.28M | 59.31%-2.56M | -0.13%-23.98M | 38.56%-6.65M | 15.52%-5.32M | -39.39%-5.65M |
| Net non-operating interest income expense | -32.60%-301K | -67.58%-920K | -28.15%-173K | -86.23%-257K | 19.16%-135K | -108.26%-227K | -24.77%-549K | -23.85%-135K | -24.32%-138K | -83.52%-167K |
| Non-operating interest expense | 32.60%301K | 67.58%920K | 28.15%173K | 86.23%257K | -19.16%135K | 108.26%227K | 24.77%549K | 23.85%135K | 24.32%138K | 83.52%167K |
| Other net income (expense) | 105.49%74K | -69.91%-2.76M | 79.80%-262K | 54.51%-318K | -403.82%-954K | -14,888.89%-1.35M | 29.29%-1.62M | -614.68%-1.3M | 28.16%-699K | 125.72%314K |
| Special income (charges) | 93.22%-85K | -7.56%-2.25M | 117.58%227K | 47.16%-363K | -591.94%-858K | -2,137.50%-1.25M | 16.10%-2.09M | -3,034.09%-1.29M | 18.02%-687K | 90.42%-124K |
| -Less：Restructuring and merger&acquisition | -93.22%85K | 7.56%2.25M | -117.58%-227K | -47.16%363K | 591.94%858K | 2,137.50%1.25M | -16.10%2.09M | 3,034.09%1.29M | -18.02%687K | -90.42%124K |
| Other non- operating income (expenses) | 265.63%159K | -208.99%-509K | -8,050.00%-489K | 475.00%45K | -121.92%-96K | -304.26%-96K | 138.27%467K | -102.88%-6K | 91.11%-12K | 491.89%438K |
| Income before tax | 47.44%-2.18M | 41.05%-15.41M | 54.31%-3.69M | 31.55%-4.21M | 38.70%-3.37M | 35.48%-4.14M | 1.99%-26.15M | 24.32%-8.08M | 16.59%-6.16M | -2.55%-5.5M |
| Income tax | 20.00%18K | -1,358.49%-667K | 70.00%17K | -5,200.00%-714K | 23.08%16K | 0.00%15K | 289.29%53K | 121.28%10K | 55.56%14K | 160.00%13K |
| Net income | 46.59%-2.25M | 43.51%-14.94M | 54.21%-3.73M | 42.88%-3.56M | 38.24%-3.45M | 35.22%-4.21M | 1.08%-26.45M | 23.63%-8.14M | 16.28%-6.23M | -5.20%-5.58M |
| Net income continuous Operations | 47.19%-2.19M | 43.72%-14.75M | 54.16%-3.71M | 43.28%-3.5M | 38.56%-3.39M | 35.40%-4.15M | 1.69%-26.2M | 23.89%-8.09M | 16.50%-6.17M | -2.70%-5.51M |
| Net income discontinuous operations | 0.00%-54K | 21.20%-197K | 60.71%-22K | 4.62%-62K | 12.12%-58K | 16.92%-54K | -184.09%-250K | -51.35%-56K | -12.07%-65K | -201.54%-66K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 46.59%-2.25M | 43.51%-14.94M | 54.21%-3.73M | 42.88%-3.56M | 38.24%-3.45M | 35.22%-4.21M | 1.08%-26.45M | 23.63%-8.14M | 16.28%-6.23M | -5.20%-5.58M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 3.03M | 0 | 0 | 0 | ||
| Net income attributable to common stockholders | 46.59%-2.25M | 49.32%-14.94M | 54.21%-3.73M | 42.88%-3.56M | 38.24%-3.45M | 55.84%-4.21M | -8.52%-29.48M | 26.09%-8.14M | 17.11%-6.23M | -5.20%-5.58M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data